|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.53 USD | +2.66% |
|
-4.97% | +2.04% |
| 18/07 | Avalo Therapeutics Says Some Shareholders May Sell Up to 128,189 Shares | MT |
| 05/07 | Certain Common Stock of Avalo Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 5-JUL-2026. | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 19.96 | 22.87 | 21.57 |
| Spread/Res. | -7.16% | -18.98% | -14.09% |
| Spread/Supp. | +7.17% | +45.45% | +99.46% |
| Support | 17.29 | 12.74 | 9.29 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AVTX Stock
- Charts Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
